Literature DB >> 3995808

Primary systemic carnitine deficiency under successful therapy: clinical, biochemical, ultrahistochemical and renal clearance studies.

W von Petrykowski, U P Ketelsen, E Schmidt-Sommerfield, D Penn, E Sawicka, E Struck, W Lehnert, K Haap, H M Strassburg.   

Abstract

Systemic carnitine deficiency is an often fatal, but treatable metabolic disorder which should be considered in any child with repeated episodes of a Reye-like syndrome or a cardiomyopathy. A 4-year-old girl with a typical history and clinical findings was successfully treated with oral carnitine. Despite low liver carnitine, ketogenesis upon fasting was normal. Normal muscle function under therapy was associated with unchanged low muscle carnitine levels. Improvement of mitochondrial structure and function was demonstrated by controlled ultrahistochemical studies. A renal carnitine leak, evident from renal clearance studies, may contribute to the pathogenesis of systemic carnitine deficiency.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3995808

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  6 in total

Review 1.  The use of levo-carnitine in children with renal disease: a review and a call for future studies.

Authors:  Brook Belay; Nora Esteban-Cruciani; Christine A Walsh; Frederick J Kaskel
Journal:  Pediatr Nephrol       Date:  2005-12-23       Impact factor: 3.714

Review 2.  Biochemical relationships between Reye's and Reye's-like metabolic and toxicological syndromes.

Authors:  J Osterloh; W Cunningham; A Dixon; D Combest
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jul-Aug

3.  Hereditary defect in carnitine membrane transport is expressed in skin fibroblasts.

Authors:  B O Eriksson; S Lindstedt; I Nordin
Journal:  Eur J Pediatr       Date:  1988-08       Impact factor: 3.183

4.  Transport of carnitine into cells in hereditary carnitine deficiency.

Authors:  B O Eriksson; B Gustafson; S Lindstedt; I Nordin
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

5.  Oral carnitine therapy in children with cystinosis and renal Fanconi syndrome.

Authors:  W A Gahl; I Bernardini; M Dalakas; W B Rizzo; G S Harper; J M Hoeg; O Hurko; J Bernar
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

6.  Mitochondrial abnormalities of muscle tissue in mice with juvenile visceral steatosis associated with systemic carnitine deficiency.

Authors:  J Miyagawa; M Kuwajima; T Hanafusa; K Ozaki; H Fujimura; A Ono; R Uenaka; I Narama; T Oue; K Yamamoto
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.